Unable to cure their kids' ultra-rare diseases, Israeli parents built company saving others

The technology of QRGenetics identifies the activity of defective proteins in children with ultra-rare disease with no cure, and seeks out existing drugs for other uses – that may change the course of the disease. Despite a long list of remarkable successes, the company is still struggling for funding